Why Did Insulet Corp (PODD) Shares Soar 10.11%?

Insulet Corp (PODD) shares surged 10.11% in pre-market trading on May 9, 2025, driven by a strong first-quarter performance that exceeded market expectations.

Insulet Corporation reported a 30% revenue growth in the first quarter of 2025, primarily driven by a 29% increase in Omnipod sales. The company's non-GAAP earnings per share (EPS) of $1.02 surpassed estimates by $0.23, reflecting robust financial performance. This strong earnings report has bolstered investor confidence in the company's growth prospects.

The company's revenue for the quarter reached $569 million, surpassing analyst estimates of $543 million. This represents a 28.8% year-on-year growth, with the company's adjusted EPS of $1.02 exceeding analyst expectations by 29.7%. The company's adjusted EBITDA of $133.9 million also outperformed estimates, with an 18.1% beat. Insulet's operating margin improved to 15.6%, up from 12.9% in the same quarter last year, while its free cash flow margin decreased to 9.1% from 14.8%.

Insulet's constant currency revenue grew by 29.8% year-on-year, indicating strong demand for its products. The company's revenue guidance for the second quarter of 2025 is $608.2 million at the midpoint, which is 5.5% above analyst expectations. This positive outlook has contributed to the stock's pre-market surge.